Cite
APA Citation
Gross, Z., Rahbari, A., Wirtschafter, E., Spektor, T. M., Udd, K. A., Bujarski, S., Ghermezi, M., Nosrati, J. D., Vidisheva, A., Eades, B., Cecchi, G., Maluso, T., Swift, R., & Berenson, J. R. (2018). elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study. European journal of haematology, 100, 621–623. http://access.bl.uk/ark:/81055/vdc_100065991012.0x000039